This is the first post in a multipart series on how medical device and pharmaceutical companies can continue to make progress on Human Factors-related activities during the COVID-19 crisis.
The rapid onset of the COVID-19 crisis has many businesses grappling with how to maintain momentum on their development programs, especially as it relates to human factors. Human Factors MD sees this as an opportunity for companies to dig in and identify opportunities for making progress on products currently under development, along with starting new ones that support the health and safety of patients, caregivers, and healthcare providers.
As a company that focuses solely on supporting these industries, we are committed to helping our clients through these challenging times. That’s why we have started this series. Topics to be covered include:
- Using remote testing to gain insights on current designs
- Getting a jump start on your human factors documentation
- Developing your labeling early to mitigate last-minute challenges
Medical device and pharmaceutical companies have a vital role in developing technology and therapies that save countless lives each day. Making the right strategic decisions and acting on them now will lay the foundation to emerge stronger on the other side.